201
Views
3
CrossRef citations to date
0
Altmetric
Short Report

The use of methotrexate in conservative treatment of placenta accreta spectrum disorders

ORCID Icon, , , &
Pages 7514-7517 | Received 16 Nov 2020, Accepted 30 Jun 2021, Published online: 18 Jul 2021

References

  • Belfort MA. Placenta accreta. Am J Obstet Gynecol. 2010;203(5):430–439.
  • Silver RM, Ware Branch D. Placenta accreta spectrum. N Engl J Med. 2018;378(16):1529–1536.
  • Wu S, Kocherginsky M, Hibbard J. Abnormal placentation: twenty-year analysis. Am J Obstet Gynecol. 2005;192(5):1458–1461.
  • Fitzpatrick KE, Sellers S, Spark P, et al. Incidence and risk factors for placenta accreta/increta/percreta in the UK: a national case-control study. PLoS One. 2012;7(12):e52893.
  • Calì G, Giambanco L, Puccio G, et al. Morbidly adherent placenta: evaluation of ultrasound diagnostic criteria and differentiation of placenta accreta from percreta. Ultrasound Obstet Gynecol. 2013;41(4):406–412.
  • Comstock C, Bronsteen R. The antenatal diagnosis of placenta accreta. BJOG. 2014;121(2):171–182.
  • Bowman ZS, Eller AG, Kennedy AM, et al. Accuracy of ultrasound for the prediction of placenta accreta. Am J Obstet Gynecol. 2014;211(2):177.e1–177.e7.
  • Salomon LJ, Alfirevic Z, Berghella V, et al. Practice guidelines for performance of the routine mid-trimester fetal ultrasound scan. Ultrasound Obstet Gynecol. 2011;37(1):116–126.
  • Cali G, Forlani F, Lees C, et al. Prenatal ultrasound staging system for placenta accreta spectrum disorders. Ultrasound Obstet Gynecol. 2019;53(6):752–760.
  • Jauniaux E, Chantraine F, Silver RM, et al. FIGO consensus guidelines on placenta accreta spectrum disorders: epidemiology. Int J Gynaecol Obstet. 2018;140(3):265–267.
  • Sentilhes L, Ambroselli C, Kayem G, et al. Maternal outcome after conservative treatment of placenta accreta. Obstet Gynecol. 2010;115(3):526–534.
  • Farasatinasab M, Moghaddas A, Dashti-Khadivaki S, et al. Management of abnormal placenta implantation with methotrexate: a review of published data. Gynecol Obstet Invest. 2016;81(6):481–496.
  • Lin K, Qin J, Xu K, et al. Methotrexate management for placenta accreta: a prospective study. Arch Gynecol Obstet. 2015;291(6):1259–1264.
  • Jauniaux E, Alfirevic Z, Bhide AG, et al. Placenta praevia and placenta accreta: diagnosis and management: green-top guideline no. 27a. BJOG. 2019;126(1):e1–E48.
  • Cahill AG, Beigi R, Heine RP, et al. Placenta accreta spectrum. Am J Obstet Gynecol. 2018;219(6):B2–B16.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.